SFDA To Hasten GMP Compliance Via Upcoming Policy Measures
This article was originally published in PharmAsia News
Executive Summary
Chinese authorities will soon release yet more pharma policy guidelines for M&As, GMP certification, price adjustments, manufacturing commission regulation, and procurement and production.